Writing in The Hill, Morgridge CEO Dr. Brad Schwartz provides insight and context for scientific discovery as a foundation for economic prosperity. As the United States looks to science to help us get past the COVID-19 pandemic, we would be well advised to also look back.
Author: Morgridge Institute for Research
Detecting cellular diversity to sharpen personalized cancer treatments
Melissa Skala, a University of Wisconsin–Madison associate professor of biomedical engineering, and collaborators have used an approach called optical metabolic imaging (OMI) to effectively assess that heterogeneity and related treatment responses in organoids created with tissues from patients with breast cancer and pancreatic cancer.
The Power List 2020
Stem cell pioneer and Morgridge investigator James Thomson was named to the Power List 2020 for his contributions to advancing the field of medicine to save lives and improve the world.
Albany Med partnering with University of Wisconsin for COVID-19 research
An Albany Medical Center Hospital physician is partnering with the University of Wisconsin–Madison to study different patient experiences with COVID-19.
Albany Med Pulmonologist Partners with University of Wisconsin on COVID-19 Research
An Albany Med physician who has been caring for COVID-19 patients during the pandemic is partnering with the Morgridge Institute and UW–Madison to study why some patients experience COVID-19 more severely than others.